Clinical Trial

A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion

Name: A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion — clinical trial record (NCT07649369)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the efficacy and safety of intrapleural JMKX000197 compared with intrapleural cisplatin in patients with malignant pleural effusion.

Trial Details

NCT Number	NCT07649369
Lead Sponsor	Shanghai Jeyou Pharmaceutical Co., Ltd.
Conditions	Malignant Pleural Effusions (Mpe)
Enrollment	120 participants
Start Date	2026-08-17
Primary Completion	2028-01-12 (estimated)
Study Completion	2028-08-14 (estimated)
Updated on ClinicalTrials.gov	2026-06-16